Results 171 to 180 of about 182,390 (296)
Development and Validation of an Interface Between the BIANCA Biophysical Model and Geant4 for Particle Therapy. [PDF]
Carante MP +5 more
europepmc +1 more source
The current status of FLASH particle therapy: a systematic review. [PDF]
Atkinson J, Bezak E, Le H, Kempson I.
europepmc +1 more source
QA Guideline for Particle Beam Therapy Equipment
Introduction: The first particle beam therapy equipment QA guideline [1] was published from Japan in 2005. However, the QA procedure, tolerance values, action levels, etc.
698308 +5 more
core
Dual acidic pH‐responsive degradable e‐spun nanofibrous mats crosslinked with acid‐labile imine and boronic ester linkages that exhibit rapid degradation and enhanced release of encapsulated anticancer drugs through their acid‐catalyzed hydrolysis and their doxorubicin‐loaded mats having desired antitumoral activity and hemocompatibility, as promising ...
Sofia Nieves Casillas‐Popova +4 more
wiley +1 more source
Editorial: 3<sup>rd</sup> international workshop on microdosimetry for particle therapy: Bridging physics and biology. [PDF]
Barna S +9 more
europepmc +1 more source
A 3D‐printed piezoionic GPMx hydrogel enables stable electromechanical signal generation under mechanical loading, exhibiting long‐term durability and low fatigue. As a bioactive patch, it restores endogenous bioelectricity to stimulate osteogenesis via Ca2+ influx and mitochondrial activation, while simultaneously enabling label‐free alkaline ...
Sayan Deb Dutta +3 more
wiley +1 more source
Novel use of peak optimized particle therapy for the delivery of three-dimensional spatially fractionated radiotherapy. [PDF]
Snider JW +9 more
europepmc +1 more source
Particle beams such as protons and heavier ions show an increase in nergy deposition with penetration depth up to a maxi-mum at the end of their range, the so-called Bragg perk. Almost no dose is deposited in normal tissue beyond the Bragg peak. The particle range is determined by the energy of the incoming particles.
openaire
Self‐assembled, scaffold‐free full‐thickness skin equivalents with monoclonal, genetically modified N/TERT‐1 keratinocytes represent a novel in vitro model of human skin and skin diseases. The model is highly robust, reproducible, physiologically relevant, and suitable for high‐throughput applications.
Marta Slaufova +4 more
wiley +1 more source
Correction and utilization of the washout effect in range-verification PET for particle therapy. [PDF]
Toramatsu C, Kanno I, Yamaya T.
europepmc +1 more source

